XHO I(81295-43-4)
- Name: XHO I
- Synonyms:E.C.3.1.23.42; EndodeoxyribonucleaseBadI; Endodeoxyribonuclease BbfI; Endodeoxyribonuclease BluI;Endodeoxyribonuclease CcrI; Endodeoxyribonuclease XhoI; EndodeoxyribonucleaseXpaI; Nuclease, Caulobacter crescentus site-specific endodeoxyribo-, CcrI;Restriction endodeoxyribonuclease XhoI; Restriction endodeoxyribonuclease XhoI;Restriction endonuclease AbrI; Restriction endonuclease AerAI; Restrictionendonuclease BadI; Restriction endonuclease BspAAI; Restriction endonucleaseBstVI; Restriction endonuclease CcrI; Restriction endonuclease MavI;Restriction endonuclease MlaAI; Restriction endonuclease Paer7I; Restrictionendonuclease Sau3239I; Restriction endonuclease SauLPII; Restrictionendonuclease Sbi68I; Restriction endonuclease SciI; Restriction endonucleaseSdiI; Restriction endonuclease Sfr274I; Restriction endonuclease SlaI;Restriction endonuclease Sol10179I; Restriction endonuclease StrI; Restrictionendonuclease TliI; Restriction endonuclease XhoI; Restriction enzyme XhoI;Site-specific endonuclease CcrI
- Molecular Formula:
- Molecular Weight:0
- CAS Registry Number:81295-43-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.81295-43-4 XHO I
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:XHO I
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.81295-43-4 XhoI
Assay:99% Appearance:white powder Package:25kg,50kg,180kg,200kg,250kg,1000kg锛宑ustomization Storage:Keep it in dry,shady and cool place Transportation:by express or by sea Application:Pharma;Industry;Agricultural;chemical reaserch
Min. Order:0
Supplier:Wuhan Circle Star Chem-medical Technology co.,Ltd. [
China (Mainland)] CAS No.81295-43-4 XHO I
Assay:95% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 132412-85-2/3-(diethylamino)-1-(2,3,4,5-tetrahydro-1,6-benzodioxocin-8-yl)propan-1-one hydrochloride
- 75-97-8/3,3-Dimethyl-2-butanone
- 72928-49-5/4-(formyloxy)-4-(isopropyl)cyclohex-1-ene-1-ethyl formate
- 10226-54-7/LOMIFYLLINE
- 70131-71-4/Tall oil, maleic anhydride, trimethylolpropane polymer
- 5843-65-2/Demethyl-Coclaurine
- 25232-44-4/A 84 (catalyst)
- 59338-87-3/Alizapride hydrochloride
- 137734-07-7/methyl (2S)-2-({[(2S,3S,4S,5R,6R)-6-{[(2S,3R,4S,5S,6S)-6-{[(1S)-1-benzyl-2-methoxy-2-oxoethyl]carbamoyl}-2-{[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-{[(1S)-1-benzyl-2-methoxy-2-oxoethyl]carbamoyl}-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-1,2,3,4,4a,5,6,6
- 110843-97-5/bis(2,2,6,6-tetramethyl-4-piperidyl) 7,11-dioxaspiro[5.5]undecane-9,9-dicarboxylate
- 74696-71-2/N-[4-(2,2,2-trifluoro-1-hydroxyethyl)phenyl]butanamide
- 2387-65-7/1,2-Benzenedicarboxylicacid, 1,2-bis[2-[2-[2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethoxy]ethoxy]ethyl]ester
- 73840-26-3/1-(4-Ethoxynaphthalen-1-yl)-1,4-pentanedione
- 5448-63-5/4-Amino-N-(2-furylmethylene)benzenesulfonohydrazide
- 7467-07-4/2-(4-methoxyphenyl)-1-phenylethanamine
- 37481-38-2/4-Methoxy-N-(1,2,3,4-tetrahydro-2-methylisoquinolin-5-yl)benzamide
- 34272-65-6/(2,4-DIMETHYL-THIAZOL-5-YL)-ACETIC ACID
- 121652-76-4/Eptastigmine tartrate
- 32615-25-1/3-{4-[(2-carboxyphenyl)amino]phenyl}tricyclo[3.3.1.1~3,7~]decane-1-carboxylic acid
- 81295-43-4/XHO I
- 609-86-9/2-AMINO-3,5-DIIODOBENZOIC ACID
- 14358-43-1/4H-Benzo[a]quinolizine,3-ethyl-1,6,7,11b-tetrahydro-9,10-dimethoxy-2-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-isoquinolinyl]methyl]-,hydrochloride (1:2), (11bS)-rel-
- 53246-19-8/trimethylstannanylium 2,3,4,5-tetramethyl-1,2,4,3,5-triazadiborolidin-1-ide
- 6039-29-8/2-[(3-bromobenzoyl)amino]-4-hydroxybenzoic acid
- 2133-81-5/alpha-2'-deoxythioguanosine
- 18913-31-0/2,3-Butadien-1-ol
- 469-83-0/Cafestol
- 84-59-3/2,6-DIBROMO-1,5-DIHYDROXYNAPHTHALENE
- 50619-38-0/3-[(2-amino-6-chloropyrimidin-4-yl)amino]-5-(hydroxymethyl)cyclopentane-1,2-diol
- 738-47-6/1,2,3,4-tetramethyl-5-[(2,3,4,5-tetramethylphenyl)methyl]benzene